NIVF
NEWGENIVF-A (NIVF)
NASDAQ
$0.87+$0.03 (+3.19%)
Price as of Jun 03, 2026 7:47 PM EDT
  • $517,373.00
    Market Cap
  • -99.92%
    1-Year Change
  • Medical Care Facilities
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 51
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

NewGen Reports Total Gain from IP Acquisition of $17.9 Million for FY 2025

NewGenIvf Group acquired advanced cytometry intellectual property, receiving a valuation of $17.9 million, which boosts the company's net asset value and marks a strategic transition from traditional IVF services to a technology-driven service provider.

10/06/2025, 8:30 AM • Benzinga

NewGen Subsidiary Secures Strategic UAE Land and Begins Exploration of Potential Real World Asset Tokenization Initiative

NewGenDigital, a subsidiary of NewGenIvf Group, has secured a strategic 110,400 sq. ft. plot in Ras Al Khaimah, UAE, and is exploring real world asset tokenization using blockchain technology, with potential sales revenue exceeding $400 million.

07/01/2025, 7:00 AM • Benzinga

Peers

Statistics

More
Day Range
$0.80
$0.94
$0.84
1-Year Range
$0.30
$3.70
$0.84
Latest Close$0.84
Change
-$0.09 (-10.11%)
Volume296,182
Market Cap$517,373.00
Shares Outstanding568,542
P/E (TTM)0.02
Diluted EPS (TTM)$36.48
Enterprise Value$4.1M

Information as of 06/03/2026

Company Profile

NEWGENIVF GROUP LTD
NEWGENIVF GROUP LTD
https://www.nivf.global
$517,373.00
Market Cap
$9.9M
Net Income
Sector: Healthcare
Industry: Medical Care Facilities
PS Tower, Bangkok, Thailand, 10110
66 2 116 9641

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Key Executives

  • Hei Yue Fong
  • Wing Fung Siu
  • Fai Chung

Current Ownership Distribution

  • Insiders1.7M (87.78%)
  • Mutual Funds240,100 (12.13%)
  • Institutions1,706 (0.09%)
  • Other0 (0.00%)